For research use only. Not for use in humans.

Anti-ADAM9 (Imgc936)

Synonyms: IMGC936 Cat.No.A3171 Purity:99%

Anti-ADAM9 (Imgc936) is a humanized antibody targeting the ADAM metallopeptidase domain 9 (ADAM9). It is a therapeutic candidate for the treatment of various cancers including non-small cell lung, pancreatic, gastric, breast, ovarian, and colorectal cancer. MW :147.66 KD.

Anti-ADAM9 (Imgc936)

Quality Control

Batch: A317101 Purity: 99% Protein concentration: 6.98mg/ml Endotoxin Level: ＜1EU/mg

99

Mechanism of Action

Description	Anti-ADAM9 (Imgc936) is a humanized antibody targeting the ADAM metallopeptidase domain 9 (ADAM9). It is a therapeutic candidate for the treatment of various cancers including non-small cell lung, pancreatic, gastric, breast, ovarian, and colorectal cancer. MW :147.66 KD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/35511740/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	2642078-62-2
Isotype	Human IgG1
Source	CHO
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.